Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. [electronic resource]
Producer: 20060707Description: 3049-58 p. digitalISSN:- 0950-9232
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- deficiency
- Adenocarcinoma -- enzymology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- enzymology
- Cell Adhesion -- drug effects
- Cell Line, Tumor -- drug effects
- Culture Media, Serum-Free -- pharmacology
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Enzyme Induction
- Female
- Fibronectins -- metabolism
- Focal Adhesion Kinase 1 -- physiology
- GTP-Binding Proteins
- Humans
- Integrin alpha4 -- metabolism
- Integrin alpha5 -- metabolism
- Integrin beta Chains -- metabolism
- Integrin beta1 -- metabolism
- Neoplasm Proteins -- antagonists & inhibitors
- Protein Glutamine gamma Glutamyltransferase 2
- RNA, Small Interfering -- pharmacology
- Transglutaminases -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.